Clinical Research in Cardiology

, Volume 99, Issue 9, pp 545–551 | Cite as

Trends in age-standardised and age-specific mortality from ischaemic heart disease in Germany

  • Falk Müller-Riemenschneider
  • Frank Andersohn
  • Stefan N. Willich
Original Paper



Research from some industrialised countries indicated a flattening of the declining ischaemic heart disease (IHD) mortality trends in certain population groups. This study aims to investigate age-standardised, as well as sex- and age-specific time trends in IHD mortality in Germany.


Using German vital statistics between 1980 and 2007, age-standardised and age-specific IHD mortality rates for men and women were calculated. Joinpoint software was used to estimate average annual percentage changes (AAPC) together with 95% confidence intervals and to identify changing trends in mortality. To account for the reunification in 1990 trends for West Germany alone were investigated in sensitivity analysis.


Since 1980, marked decreases in mortality of 50% in men and 39% in women were observed, with AAPC of 2.4 and 1.5%, respectively. While moderate declines in mortality were observed since the early 1980s in men, significant decreases in women were only found after 1995. Trends in mortality varied substantially across age groups, showing decreases in older age (75+ years) only during the last 5–10 years. A flattening of mortality declines was not observed. In West Germany, overall decreases and AAPC were larger and differences between men and women were somewhat smaller.


German IHD mortality trends present a complex picture with profound decreases since 1980. However, declines were smaller and delayed compared to other industrialised countries. Also, time trends were not homogeneous in men and women, as well as across age groups. Preventive measures need to be strengthened to account for failures in the past and to counter the increasing burden of modifiable risk factors.


Ischaemic heart disease Mortality Germany Trend 


  1. 1.
    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMedGoogle Scholar
  2. 2.
    Sans S, Kesteloot H, Kromhout D (1997) The burden of cardiovascular diseases mortality in Europe Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 18:1231–1248Google Scholar
  3. 3.
    Morris RW, Whincup PH, Emberson JR, Lampe FC, Walker M, Shaper AG (2003) North–south gradients in Britain for stroke and CHD: are they explained by the same factors? Stroke 34:2604–2609CrossRefPubMedGoogle Scholar
  4. 4.
    Muller-Nordhorn J, Rossnagel K, Mey W, Willich SN (2004) Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Community Health 58:481–485CrossRefPubMedGoogle Scholar
  5. 5.
    Muller-Nordhorn J, Binting S, Roll S, Willich SN (2008) An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 29:1316–1326CrossRefPubMedGoogle Scholar
  6. 6.
    Shaw LJ, Bugiardini R, Merz CN (2009) Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54:1561–1575CrossRefPubMedGoogle Scholar
  7. 7.
    Passa P (2002) Diabetes trends in Europe. Diabetes Metab Res Rev 18 Suppl 3:S3–S8Google Scholar
  8. 8.
    Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290:199–206CrossRefPubMedGoogle Scholar
  9. 9.
    Helmert U, Strube H (2004) The development of obesity in Germany in the period from 1985 until 2000. Gesundheitswesen 66:409–415CrossRefPubMedGoogle Scholar
  10. 10.
    Galobardes B, Costanza MC, Bernstein MS, Delhumeau C, Morabia A (2003) Trends in risk factors for lifestyle-related diseases by socioeconomic position in Geneva, Switzerland, 1993–2000: health inequalities persist. Am J Public Health 93:1302–1309CrossRefPubMedGoogle Scholar
  11. 11.
    Stamatakis E, Ekelund U, Wareham NJ (2007) Temporal trends in physical activity in England: the health survey for England 1991 to 2004. Prev Med 45:416–423CrossRefPubMedGoogle Scholar
  12. 12.
    Drechsler K, Fikenzer S, Sechtem U, Blank E, Breithardt G, Zeymer U, Niebauer J (2008) The Euro Heart Survey - Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol 97:364–370CrossRefPubMedGoogle Scholar
  13. 13.
    Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:937–952CrossRefPubMedGoogle Scholar
  14. 14.
    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De BG, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op RW, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De CR, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28:2375–2414CrossRefPubMedGoogle Scholar
  15. 15.
    Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN (2008) Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15:239–246CrossRefPubMedGoogle Scholar
  16. 16.
    Ogden LG, He J, Lydick E, Whelton PK (2000) Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35:539–543PubMedGoogle Scholar
  17. 17.
    Critchley J, Capewell S (2004) Smoking cessation for the secondary prevention of coronary heart disease. Cochrane database of systematic reviews (Online) 3041Google Scholar
  18. 18.
    Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994) Lancet 344:1383–1389Google Scholar
  19. 19.
    JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice (2005) Heart 91 Suppl 5: v1–52Google Scholar
  20. 20.
    Genser B, Marz W (2006) Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis. Clin Res Cardiol 95:393–404CrossRefPubMedGoogle Scholar
  21. 21.
    Wienbergen H, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Gohlke H, Senges J (2008) Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol 97:83–88CrossRefPubMedGoogle Scholar
  22. 22.
    Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138–1145CrossRefPubMedGoogle Scholar
  23. 23.
    Ford ES, Capewell S (2007) Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50:2128–2132CrossRefPubMedGoogle Scholar
  24. 24.
    Allender S, Scarborough P, O’Flaherty M, Capewell S (2008) Patterns of coronary heart disease mortality over the 20th century in England and Wales: possible plateaus in the rate of decline. BMC Public Health 8:148CrossRefPubMedGoogle Scholar
  25. 25.
    O’Flaherty M, Bishop J, Redpath A, McLaughlin T, Murphy D, Chalmers J, Capewell S (2009) Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ 339:b2613CrossRefPubMedGoogle Scholar
  26. 26.
    O’Flaherty M, Ford E, Allender S, Scarborough P, Capewell S (2008) Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart 94:178–181CrossRefPubMedGoogle Scholar
  27. 27.
    Federal Statistical Office (Statistisches Bundesamt). Federal Health Monitoring (Gesundheitsberichterstattung des Bundes), last accessed 4th January 2010.
  28. 28.
    Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369CrossRefPubMedGoogle Scholar
  29. 29.
    Thefeld W (1999) Prevalence of diabetes mellitus in the adult German population. Gesundheitswesen 61 Spec No:S85–S89Google Scholar
  30. 30.
    Muller-Riemenschneider F, Nocon M, Willich SN (2009) Prevalence of modifiable cardiovascular risk factors in German adolescents. Eur J Cardiovasc Prev RehabilGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Falk Müller-Riemenschneider
    • 1
  • Frank Andersohn
    • 1
  • Stefan N. Willich
    • 1
  1. 1.Institute for Social Medicine, Epidemiology, and Health EconomicsCharité University Medical CenterBerlinGermany

Personalised recommendations